"10.1371_journal.pone.0083881","plos one","2013-12-26T00:00:00Z","Soo Jung Um; Stephen Lam; Harvey Coxson; Shu Fan Paul Man; Don D Sin","UBC James Hogg Research Centre for Cardiovascular and Pulmonary Research, St. Paulâ€™s Hospital/Providence Health Care, University of British Columbia, Vancouver, BC, Canada; Department of Medicine (Division of Respiratory Medicine), University of British Columbia, Vancouver, BC, Canada; BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada; Department of Medicine (Division of Respiratory Medicine), Dong-A University, Busan, Korea","Conceived and designed the experiments: DDS SL HC SFPM. Performed the experiments: SJU DDS. Analyzed the data: SJU DDS. Contributed reagents/materials/analysis tools: SL DDS SFPM. Wrote the paper: SJU DDS SL HC SFPM.","Budesonide and formoterol are marketed by AstraZeneca, the funder of this study. DDS has received research grants from AstraZeneca and Boerhinger Ingelheim over the past 36 months. He has received honoraria for speaking engagements from Merck and AstraZeneca and has sat on advisory boards for Merck, Takeda, Novartis, AstraZeneca and Almirall. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","12","Soo Jung Um","SJU",5,TRUE,4,2,2,5,TRUE,TRUE,FALSE,0,NA,FALSE
